Your browser doesn't support javascript.
loading
Disease activity trajectories in juvenile dermatomyositis from childhood to adulthood.
Nozawa, Tomo; Pullenayegum, Eleanor M; Bell-Peter, Audrey; Marcuz, Jo-Anne; Whitney, Kristi; Vinik, Ophir; Shupak, Rachel; Dover, Saunya; Feldman, Brian M.
Afiliação
  • Nozawa T; Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Pullenayegum EM; Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama City, Kanagawa, Japan.
  • Bell-Peter A; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Marcuz JA; Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
  • Whitney K; Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Vinik O; Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Shupak R; Department of Rehabilitation, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Dover S; Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Feldman BM; Department of Rehabilitation, The Hospital for Sick Children, Toronto, Ontario, Canada.
Article em En | MEDLINE | ID: mdl-38216715
ABSTRACT

OBJECTIVES:

To assess whether there are identifiable subgroups of disease activity trajectory in a population of juvenile dermatomyositis (JDM) patients-followed throughout childhood and into adulthood-and determine factors that predict those trajectory groupings.

METHODS:

This is a retrospective, longitudinal inception cohort of patients with idiopathic inflammatory myopathies, largely JDM. We sought to identify baseline factors that predict membership into different groups (latent classes) of disease activity trajectory.

RESULTS:

A total of 172 patients (64% females), with median age at diagnosis of 7.7 years, were analyzed. We studied 4,725 visits (1,471 patient-years). We identified 3 latent classes of longitudinal disease activity, as measured by the modified disease activity score (DASm), with distinct class trajectories predicted by DASm at baseline, and by the changes of DASm from either baseline to 3 months or baseline to 6 months (early response to therapy). In the analysis in which DASm at baseline and the changes of DASm from baseline to 6 months are included as predictors, Class 1 (10%) has persistently high disease activity, Class 2 (34%) is characterized by moderate disease activity, and Class 3 (56%) is characterized by individuals with a high early disease activity but an apparently good response to treatment and long-term low disease activity.

CONCLUSION:

High early disease activity, and treatment resistance in the first few months, predict a more chronic longitudinal course of JDM.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article